5.4med
CVE-2017-2092
Cross-site scripting vulnerability in Cybozu Garoon 3.0.0 to 4.2.3 allows remote authenticated attackers to inject arbitrary web script or…
Published 9 y ago · modified 4 mo ago · JSON
CVSS
5.4
v3.0 · NVD
CISA KEV
No
not known exploited
EPSS
0.9%
percentile 60%
Public exploits
0
none known
Summary
Cross-site scripting vulnerability in Cybozu Garoon 3.0.0 to 4.2.3 allows remote authenticated attackers to inject arbitrary web script or HTML via unspecified vectors.
Exploit prediction (EPSS)
0.89% probability of exploitation in the next 30 days, higher than 60% of all scored CVEs.
CVSS scores
| Assigned by | Version | Score | Vector |
|---|---|---|---|
| NVD | 3.0 | 5.4 | CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N |
| NVD | 2.0 | 3.5 | AV:N/AC:M/Au:S/C:N/I:P/A:N |
Affected products
- Cybozu, Inc. Cybozu Garoon
Classification
- Weakness
- CWE-79 Improper Neutralization of Input During Web Page Generation
References
- support.cybozu.com /ja-jp/article/9555 · x_refsource_MISC, x_transferred
- jvn.jp /en/jp/JVN73182875/index.html · third-party-advisory, x_refsource_JVN, x_transferred
- securityfocus.com /bid/96429 · vdb-entry, x_refsource_BID, x_transferred
Sources
- CVE List: CVE-2017-2092
- NVD: CVE-2017-2092
vulnwire keeps one entry per vulnerability: the CVE id wins, then GHSA; records that alias each other are merged. Machine-readable: JSON.